Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

inflammation · Mechanism Report

What can low albumin indicate?

Low albumin can occur with inflammation but is nonspecific and may have several other causes.

PlausibleNovember 18, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Albumin is a negative acute-phase protein that can decrease during inflammation, but low albumin is nonspecific and can also reflect reduced synthesis, inadequate protein availability, malabsorption, or protein loss.

laying out figure…
3 of 8 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

Inflammation can lower albumin through changes in liver production, redistribution from the bloodstream, and increased breakdown. Reduced synthesis, protein loss, inadequate protein availability, malabsorption, and fluid dilution can also contribute, so albumin alone cannot identify the cause.

Verified conclusion

Albumin is synthesized in the liver and serves important transport and oncotic functions, but its serum concentration is primarily a contextual clinical signal—not a diagnosis of inflammation, malnutrition, or liver disease.

Clinical and etiologic interpretation

  • Inflammation can lower albumin as a negative acute-phase response. Inflammatory cytokines, including IL-6 and IL-1, can alter hepatic albumin expression while prioritizing positive acute-phase protein production.
  • Reduced synthesis is an established cause, especially with advanced chronic hepatic impairment.
  • Protein loss through the kidneys or gastrointestinal tract, including protein-losing enteropathy, is also an established cause.
  • Severe inadequate protein availability can contribute by limiting amino-acid substrate for albumin synthesis. Malabsorption is a clinically plausible contributor through reduced effective nutrient availability, but neither poor intake nor malabsorption can be diagnosed from albumin alone.

Mechanisms

  • During acute inflammation, increased endothelial/capillary permeability redistributes albumin from plasma into the interstitial space, lowering the measured serum concentration.
  • Inflammation and systemic illness may also increase albumin catabolism. Fluid overload can lower the measured concentration through dilution.
  • Consequently, hypoalbuminemia can develop through altered distribution, loss, breakdown, dilution, and/or impaired production; several processes may coexist.

Clinical implications

  • Albumin should not be used alone as a marker of malnutrition, body-protein stores, hepatic synthetic function, or inflammation. CRP and/or ESR are more appropriate adjuncts when inflammation is suspected.
  • Interpretation should incorporate the trajectory, volume status, symptoms, liver testing, nutritional assessment, and evaluation for renal or gastrointestinal loss. Urinalysis with quantitative urine protein testing can assess renal loss; fecal α1-antitrypsin clearance may support suspected enteric protein loss.

Bottom line

  • The claim is substantially correct: low albumin is nonspecific and warrants investigation of inflammation, hepatic synthesis, protein loss, nutrition, malabsorption, and fluid/distributional factors rather than attribution to any single cause.

References

  1. Review Article: Albumin and Its Role in Inflammatory Bowel ... — pmc.ncbi.nlm.nih.gov ↗
  2. Review Article: Albumin and Its Role in Inflammatory Bowel Disease: The Old, the New, and the Future — pmc.ncbi.nlm.nih.gov ↗
  3. Physiology, Acute Phase Reactants - StatPearls - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  4. The Use of Visceral Proteins as Nutrition Markers: An ASPEN Position Paper — aspenjournals.onlinelibrary.wiley.com ↗
  5. Immunologic and Plasma Protein Disorders - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  6. Hypoalbuminemia - StatPearls - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  7. Hypoalbuminemia - StatPearls - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  8. The clinical significance of hypoalbuminaemia — nottingham-repository.worktribe.com ↗
  9. Nutritional Laboratory Markers in Malnutrition — pmc.ncbi.nlm.nih.gov ↗
  10. Protein-Losing Enteropathy - StatPearls - NCBI Bookshelf — ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible6 sourcesCan chronic osteomyelitis and deep wound infections sustain systemic inflammation?→Supported9 sourcesCan an oral infection cause systemic inflammation or a remote Klebsiella wound infection?→